UBS Initiates Kardigan at Buy With $25 Price Target

Kardigan, Inc. (KARD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates Continued to advance the development of three late-stage programs, supported by the Prolaio platform, aimed at addressing cardiovascular diseases where no approved treatm

Apple's display development leadership changes, with Victor Yin taking over from Wei Chen and John Zhong, who will advise. Other engineering leaders promoted. Johny Srouji's role expanded to chief hardware officer. Some hardware program managers laid off.

Moderna and Merck announced that their personalized mRNA vaccine, intismeran autogene, reduced melanoma recurrence or death risk by 42% in a Phase 3 trial. The vaccine is tailored to each patient's tumor. Full results are expected in 2026, but early data caused Moderna's shares to drop 25%. The companies are engaging with regulators for approval.

Indian stock markets fell on Monday, with Sensex down 0.74% and Nifty 50 down 0.94%, driven by IT stock declines and crude oil price concerns. Infosys, HCL Tech, and other IT stocks led losses. Investors await the US Federal Reserve's policy decision. Crude oil prices eased but remain high, impacting inflation and corporate margins.

AstraZeneca's experimental drug Sone-ve (sonesitatug vedotin) doubled median survival to 10 months in advanced stomach cancer patients vs. 5 months with chemotherapy, per late-stage trial data presented at ESMO Congress. The drug showed a 53% reduction in death risk but missed its progression-free survival goal. AstraZeneca aims for regulatory approvals and sees potential peak sales of $3B-$5B.

L&T Technology Services (LTTS) has secured a five-year deal with Nokia for R&D support in India. The agreement focuses on product engineering, new product development, and system integration, with LTTS setting up a dedicated Offshore Development Center. Nokia aims to enhance its innovation capabilities and expand its R&D presence in India, according to the companies.